Abstract
Background: Despite recent advances in improved glycemic control, the magnitude of lifetime risk from premature cardiovascular disease in individuals with type 1 diabetes remains at least 10 fold higher than in the general population. The availability of lipoprotein fractionation has allowed the spotlight for this increased risk to shift from dysglycemia to diabetes-induced dyslipidemia associated with insulin resistance. Interventions designed to simultaneously improve both factors can have distinct and additive effects on slowing the initiation and progression of atherosclerotic lesions. As fullblown cardiovascular disease is not evident during childhood, there is a critical need to identify the most predictable surrogate markers that could assign elevated risk, as well as the design of safe and targeted interventions that could improve outcomes in this population.
Conclusion: This review will examine the evidence supporting the notion that cardiovascular disease in type 1 diabetes is associated with significant insulin resistance and it begins in childhood, making it necessary to design rational clinical trials that will significantly reduce risk in this population.
Keywords: Cardiovascular disease, dyslipidemia, HbA1c, insulin resistance, lipoproteins, statins, systematic review, type 1 diabetes.
Current Diabetes Reviews
Title:Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes
Volume: 13 Issue: 6
Author(s): Jose A. Canas, Samuel S. Gidding and Nelly Mauras*
Affiliation:
- Pediatric Endocrinology, Diabetes & Metabolism, Nemours Children's Health System, 807 Children's Way, Jacksonville, FL 32207,United States
Keywords: Cardiovascular disease, dyslipidemia, HbA1c, insulin resistance, lipoproteins, statins, systematic review, type 1 diabetes.
Abstract: Background: Despite recent advances in improved glycemic control, the magnitude of lifetime risk from premature cardiovascular disease in individuals with type 1 diabetes remains at least 10 fold higher than in the general population. The availability of lipoprotein fractionation has allowed the spotlight for this increased risk to shift from dysglycemia to diabetes-induced dyslipidemia associated with insulin resistance. Interventions designed to simultaneously improve both factors can have distinct and additive effects on slowing the initiation and progression of atherosclerotic lesions. As fullblown cardiovascular disease is not evident during childhood, there is a critical need to identify the most predictable surrogate markers that could assign elevated risk, as well as the design of safe and targeted interventions that could improve outcomes in this population.
Conclusion: This review will examine the evidence supporting the notion that cardiovascular disease in type 1 diabetes is associated with significant insulin resistance and it begins in childhood, making it necessary to design rational clinical trials that will significantly reduce risk in this population.
Export Options
About this article
Cite this article as:
Canas A. Jose, Gidding S. Samuel and Mauras Nelly*, Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes, Current Diabetes Reviews 2017; 13 (6) . https://dx.doi.org/10.2174/1573399813666170113142621
DOI https://dx.doi.org/10.2174/1573399813666170113142621 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Determination of Selenium in Eggs of Different Birds Using Sample Digestion in a Reflux System and Hydride Generation Atomic Fluorescence Spectrometry
Current Analytical Chemistry Inflammaging and Proteases in Abdominal Aortic Aneurysm
Current Vascular Pharmacology MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Current Medicinal Chemistry Recent Patents in Plant Biotechnology: Impact on Global Health
Recent Patents on Biotechnology microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design Hazelnut Modulates Neurobehaviour and Ameliorates Ageing-induced Oxidative Stress, and Caspase-3-Mediated Apoptosis in Mice
Current Aging Science Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Molecular Function of Tocopherols in Age Related Diseases
Current Pharmaceutical Design Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine Therapeutic Advances in the Treatment of Alzheimer's Disease: Present and Future
Current Drug Therapy Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Primary Prevention of Cardiovascular Risk in Octogenarians by Risk Factors Control
Current Hypertension Reviews Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design Environmental Pollution and Diabetes Mellitus
Recent Patents on Biomarkers Is There An Association Between Vitamin D and Hypertension?
Recent Patents on Cardiovascular Drug Discovery Virgin Olive Oil and Hypertension
Current Vascular Pharmacology Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry